Blood Component Transfusion
"Blood Component Transfusion" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The transfer of blood components such as erythrocytes, leukocytes, platelets, and plasma from a donor to a recipient or back to the donor. This process differs from the procedures undertaken in PLASMAPHERESIS and types of CYTAPHERESIS; (PLATELETPHERESIS and LEUKAPHERESIS) where, following the removal of plasma or the specific cell components, the remainder is transfused back to the donor.
| Descriptor ID |
D016913
|
| MeSH Number(s) |
E02.095.135.140
|
| Concept/Terms |
Blood Component Transfusion- Blood Component Transfusion
- Blood Component Transfusions
- Component Transfusion, Blood
- Component Transfusions, Blood
- Transfusion, Blood Component
- Transfusions, Blood Component
|
Below are MeSH descriptors whose meaning is more general than "Blood Component Transfusion".
Below are MeSH descriptors whose meaning is more specific than "Blood Component Transfusion".
This graph shows the total number of publications written about "Blood Component Transfusion" by people in this website by year, and whether "Blood Component Transfusion" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2016 | 1 | 0 | 1 |
| 2017 | 15 | 2 | 17 |
| 2018 | 1 | 6 | 7 |
| 2019 | 4 | 2 | 6 |
| 2020 | 8 | 10 | 18 |
| 2021 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Blood Component Transfusion" by people in Profiles.
-
Early Convalescent Plasma Therapy and Mortality Among US Veterans Hospitalized With Nonsevere COVID-19: An Observational Analysis Emulating a Target Trial. J Infect Dis. 2021 09 17; 224(6):967-975.
-
Transfusion-related acute lung injury in a COVID-19-positive convalescent plasma recipient: a case report. J Int Med Res. 2021 Aug; 49(8):3000605211032814.
-
Impact of the early coronavirus disease 2019 pandemic on blood utilization in the United States: A time-series analysis of data reported to the National Healthcare Safety Network Hemovigilance Module. Transfusion. 2021 09; 61 Suppl 2:S36-S43.
-
Treating the endotheliopathy of SARS-CoV-2 infection with plasma: Lessons learned from optimized trauma resuscitation with blood products. Transfusion. 2021 07; 61 Suppl 1:S336-S347.
-
[Therapeutic Effect of Convalescent Plasma Transfusion on Fulminant Viral Infectious Diseases--Review]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2021 Jun; 29(3):988-992.
-
Randomized clinical trial to evaluate safety and efficacy of convalescent plasma use among hospitalized patients with COVID-19 (PERUCONPLASMA): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):342.
-
Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial. Trials. 2021 May 17; 22(1):343.
-
Convalescent Plasma Transfusion for the Treatment of COVID-19 in Adults: A Global Perspective. Viruses. 2021 05 07; 13(5).
-
Safety of Convalescent Plasma Transfusion. Mayo Clin Proc. 2021 05; 96(5):1368-1369.
-
In Reply - Safety of Convalescent Plasma Transfusion. Mayo Clin Proc. 2021 05; 96(5):1369.